Birth is a highly stressful and critical event. In the womb, babies rely on the supply of oxygen and nutrients provided by the placenta. However, once they are born they need to breathe for themselves and gain all their nutrients from suckling milk. The placenta provides a sugar-rich diet, while milk is richer in fat. Failing to cope with this change in diet leads to serious complications and sometimes death. Therefore, a better understanding of how the body adapts to these changes may shed light on pathways that are important for good health in later life.

The liver plays a central role in processing the nutrients absorbed by the gut. It uses fats to produce molecules called ketone bodies, such as β-hydroxybutyrate, which are then used as fuel by other tissues and organs including the heart, muscle and the brain. A protein called PPARα controls the production of ketone bodies primarily by regulating genes that are involved in the uptake and breakdown of fat in the liver. However, little is known about how this protein affects the development of the liver.

Here, Rando, Tan et al. report that mice start to produce more PPARα in the liver shortly before birth. This ultimately activates several genes that encode enzymes that break down fats. The experiments show that during labor, stress hormones called glucocorticoids directly stimulate the production of PPARα in the liver of the fetus to prepare newborn mice for harnessing energy from fat-rich milk.

In the absence of PPARα, mouse liver cells are less able to break down fats after birth and so start to accumulate fat, resulting in fewer ketone bodies being produced. Rando, Tan et al. show that β-hydroxybutyrate regulates some PPARα target genes, including one called Fgf21. The activity of this gene increases only after milk suckling starts and it encodes a protein that enhances the breakdown of fats in the liver. Without PPARα, the expression levels of its target genes, including Fgf21, do not increase after birth, which promotes the build up of fats in liver cells, a condition known as liver steatosis.

Overall, the results reported by Rando, Tan et al. highlight how stress during labor plays an important role in priming the body to cope with a fat-rich diet after birth. Future studies will need to determine if stress hormones and ketone bodies could be used as therapies for babies born by caesarean section with liver steatosis.

In mammals, embryonic and postnatal development depends on nutrition from placentation and lactation, respectively (Brawand et al., 2008).Before birth, hepatic energy metabolism relies mainly on glucose catabolism. Metabolic fluxes change abruptly at birth when milk, which has a higher lipid but relatively lower glucose content, becomes the exclusive nutrient (Girard et al., 1992). At the first few hours after birth, liver expresses the rate-limiting enzymes responsible for extracting energy from milk (Krahling et al., 1979; Huyghe et al., 2001). However, whether lipid catabolism at birth is developmentally programmed or an adaptive response requiring an external stimulus remains unknown. Failure to adapt to this catabolic switch results in life-threatening errors of metabolism, with serious energy imbalances that are recapitulated in mouse models of neonatal liver steatosis (Ibdah et al., 2001; Cherkaoui-Malki et al., 2012).

Peroxisome proliferator-activated receptor α (PPARα) is a key transcriptional regulator of lipid metabolism owing to its activation by a lipid surge to induce lipid catabolism (Desvergne et al., 2006; Montagner et al., 2011, 2016). However,the role of PPARα in the perinatal liver is not fully understood. Certain PPARα target genes (e.g., acyl-CoA oxidase 1 [Acox1]) are highly expressed in fetal liver at the end of gestation, whereas the expression of others (e.g., fibroblast growth factor 21 [Fgf21]) strictly depends on postnatal milk uptake (Hondares et al., 2010; Yubero et al., 2004). Based on these contrasting observations, we hypothesized the presence of a PPARα-triggering program before birth that does not require milk suckling for activation. Given that fetal liver metabolism mostly relies on glycolysis rather than lipid oxidation, we postulated that the liver phenotype of PPARα-deficient fetuses may not be obvious due to the absence of a lipid-rich diet challenge.

By measuring gene expression in prenatal and postnatal livers, we show that PPARα activation has already occurred a few days before birth, and that glucocorticoid receptor (GR)-mediated control of PPARα in late gestation prepares its physiological role in the pups for harnessing milk lipids immediately after birth. However, before birth we could barely detect the expression of certain PPARα target genes such as Fgf21, which is exclusively involved in adaptive metabolism. Therefore, we explored the mechanistic basis for the temporal regulation of PPARα target genes. We found that certain PPARα target genes, including Fgf21 and Angptl4 (Angiopoietin-like 4), are epigenetically controlled by histone deacetylase 3 (HDAC3) and de-repressed in response to β-hydroxybutyrate, a by-product of fatty acid oxidation (FAO). Taken together, our data provide the evidence of a major role of glucocorticoid signaling in direct hepatic regulation of PPARα and indirect HDAC3-mediated regulation of FGF21, which controls important metabolic and thermogenic events in the early days of life (Hondares et al., 2010).

In mammals, the transition to extra-uterine life represents a sudden shift in the source of energy (i.e., from a carbohydrate-laden fetal diet to a high-fat, low-carbohydrate diet). The neonatal liver must coordinate hepatic FAO, gluconeogenesis, and ketogenesis in order to maintain bioenergetic homeostasis and to meet the metabolic demands associated with extra-uterine life which depends exclusively on milk (Cotter et al., 2013). In contrast to the carbohydrate-replete nutrient state experienced in utero, neonatal energy is dominated by PPARα-dependent transcriptional regulation of lipid catabolism. We found that this anticipatory regulation of PPARα activity and lipid metabolism is directly controlled by GR before birth.

Glucocorticoid hormones are crucial in the functional maturation of many key tissues, notably in preparation for birth (Cottrell and Seckl, 2009). The initiation of parturition is marked by short bursts of stress hormones (Barlow et al., 1974). We demonstrate that this short burst of glucocorticoids at the initiation of birth directly stimulate the GR-dependent transcription of PPARα and its lipid catabolic target genes, which in turn prepare neonates for the sudden shift to fat-rich milk diet as the primary source of energy (Figure 8A,B). Indeed, we previously demonstrated the GR-mediated hormonal induction of PPARα in adult hepatocytes (Lemberger et al., 1994), while others showed that ligand-activated PPARα interferes with the recruitment of GR and Pol2 to the promoter of classical GRE-driven genes, inhibiting their transcription (Bougarne et al., 2009). This is also consistent with our observation of a reduced expression of Nr3c1 in Ppara^-/- livers, implicating a reciprocal regulatory relationship between GR and PPARα.

Figure 8

Download asset Open asset

We indicate that lipid catabolic target genes of PPARα, particularly those involved in mitochondrial, peroxisomal, and microsomal oxidation, are switched on just before birth in anticipation of a postpartum lipid-rich meal. In the neonatal liver, however, we show that mitochondrial β-oxidation prevails as the major contributor to the neonatal oxidative capacity and protects against hepatic steatosis when faced with a sudden surge in dietary fat. Our findings are consistent with the notion that mitochondrial FAO represents the dominant metabolic pathway whereas peroxisomal FAO assumes a relatively minor role (Hashimoto et al., 1999). Accordingly, long-chain FAs constitute more than 60% of the total FAs in animals and milk (Smith et al., 1968), and their abundance makes them the only significant source of metabolic fuel for the mitochondrial, but not peroxisomal, β-oxidation system (Reddy and Mannaerts, 1994). Moreover, decreased mitochondrial FAO has been considered one of the major contributing factors leading to liver steatosis (Ockner et al., 1993). Thus, we conclude that the concomitant presence of lipid content of milk, a lower number of mitochondria and overt mitochondrial dysfunctions jointly contributes to the development of liver steatosis in Ppara^-/-neonates. Notably, mitochondrial dysfunctions were evident in Ppara^-/- hepatocytes due to reduced ∆_ΨM and increased intracellular ROS levels. We postulate that an increased intracellular ROS level likely precedes the loss of ∆_ΨM and mitochondria dysfunction. As this oxidative stress condition continues to worsen after birth, perhaps induced by nutritional lipid as previously indicated (Tirosh et al., 2009), reduced ∆_ΨM and ATP production ultimately ensue. This is in agreement with a previous report of a similar mitochondrial disorder associated with the dysfunctional respiratory chain components (Lebiedzinska et al., 2010). Particularly, the increased intracellular ROS levels observed in Ppara^-/- hepatocytes may be due to the reduced clearance of ROS as evidenced by the down-regulation of genes coding for mitochondrial superoxide dismutase 2 (SOD2) and copper chaperone for SOD1 (a metalloprotein responsible for delivering copper as a co-factor to SOD1) before and/or after birth (Figure 2—source data 1). This observation is consistent with the report that PPARα activation by agonist clofibrate stimulates SOD1 and catalase activities as part of the defense mechanisms against oxidative stress in the heart (Ibarra-Lara et al., 2016).

Many of the PPARα-regulated genes involved in FAO have previously been shown to contain a PPRE in their promoter region and hence, recognized as direct PPARα target genes (Rakhshandehroo et al., 2010). This implicates that the reduced oxidative capacity observed in Ppara^-/- mice was due to the lack of direct PPARα-mediated stimulatory effects rather than a cellular-autonomous metabolic adaptation in response to lower mitochondria numbers. As discovered by Semenkovich andRakhshandehroo et al., 2010 co-workers (Chakravarthy et al., 2005, 2009), newly synthesized FA by fatty acid synthase may also regulate glucose, lipid, and cholesterol metabolism by serving as endogenous activators of a distinct physiological pool of PPARα ligands in adult liver. However, we doubt that de novo synthesis of FA plays a predominant role in the regulation of PPARα activity during early postnatal period since insulin/glucagon ratio is low, which promotes FAO rather than de novo synthesis of FA (Girard et al., 1977). Our recent work indicates that PPARα has little impact on the expression of lipogenic genes in normal conditions (Montagner et al., 2016). Moreover, an effective hepatic FAO is essential for the provision of acetyl-CoA and NADH to support hepatic de novo ketogenesis and gluconeogenesis (Girard, 1986). This notion is consistent with the hypoketonemia and hypoglycemia in Ppara^-/-neonates reported in this work and by Crawford and co-workers (Cotter et al., 2014). Notably, the hypoglycemic phenotype previously reported in Ppara^-/-neonates by Cotter et al. happened at P1 due to a decreased hepatic gluconeogenesis from glycerol. However, we did not detect any sign of hypoglycemia in these mice starting from P2. This apparent discrepancy is likely attributable to the rapid (~1 day) and dynamic adaptive functions of Ppara^-/- neonatal liver in providing glucose as the primary source of energy required for postnatal growth and in maintaining glucose homeostasis. Our finding also supports the work of others indicating a preserved gluconeogenesis from glycerol in adult Ppara^-/- mice (Xu et al., 2002). We elucidated that this cell-autonomous metabolic adaptation was enhanced in the absence of PPARα and mediated through the up-regulation of hepatic ALT and anaplerotic amino acid oxidation. Thus far, the mechanism behind the increased production and secretion of ALT in Ppara^-/- neonatal liver still remains unclear. It is notable that ALT2 expression is up-regulated under metabolic stress and that plasma and tissue ALT levels are elevated in response to endoplasmic reticulum (ER) stress (Salgado et al., 2014; Josekutty et al., 2013). Interestingly, defective PPARα signaling has been reported to cause hepatic mitochondrial and ER stress in the pathogenesis of hepatic steatosis through reduced mRNA expression of the sarco/endoplasmic reticulum calcium ATPase (SERCA) (Su et al., 2014). In addition, our transcriptome analysis revealed a consistent reduction by ~1.2-fold in the expression of Atp2a2, which encodes SERCA, in Ppara^-/- liver at E19.5 and P2 (Figure 2—source data 1). Moreover, we also delineated that most of the rate-limiting enzymes involved in amino acid oxidation were concomitantly up-regulated in Ppara^-/- neonatal liver to provide essential intermediate substrates in TCA/Krebs cycle required for gluconeogenesis. Hence, we speculate that de novo synthesis of glucose becomes the primary energy source in sustaining normal postnatal growth in Ppara^-/- neonates as evidenced by the observed growth retardation upon decoupling of amino acid oxidation from gluconeogenesis. This is in conjunction with the failure of Ppara^-/- neonatal liver in harnessing energy from ketone bodies and lipids due to defective mitochondrial functions. In parallel, the compensatory up-regulation of pyruvate carboxylase (Pcx) and other gluconeogenic genes in Ppara^-/-neonates at P2 probably corresponds with a lower hepatic acetyl-CoA level, as supported by a recent report that hepatic acetyl-CoA acts as an allosteric regulator of Pcx (Perry et al., 2015). Importantly, these findings in Ppara^-/-mice illustrate the tremendous flexibility of the neonatal liver in coordinating ketogenesis, FAO, and gluconeogenesis so as to meet the energy demand required for normal growth especially when faced with an energy crisis caused by defective oxidative metabolism and hypoketonemia.

Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) is one of the rate-liming enzymes involved in ketogenesis. Hmgcs2 contains a PPRE in its promoter region and is under the direct transcriptional control of PPARα (Rodríguez et al., 1994). HMGCS2 has been shown to induce mitochondrial FAO and FGF21 expression, possibly via a SIRT1-dependent mechanism (Vilà-Brau et al., 2011). Furthermore, Hmgcs2 mRNA expression peaks 16 hr after birth and coincides with a decline in Acox1 mRNA expression thereafter (Yubero et al., 2004; Serra et al., 1993, 1996). These reports substantiate our findings of preferential activation of mitochondrial FAO at birth. Our results also support the in vivo finding that β-hydroxybutyrate is a potent physiological inhibitor of HDAC3 (Shimazu et al., 2013), suggesting that PPARα-mediated activation of HMGCS2 and β-hydroxybutyrate production precedes the PPARα-regulated production of FGF21. Similar to other PPARα target genes, we detected PPARα occupancy in the Fgf21 promoter before birth, but its transcription is ultimately determined by the alleviation of HDAC3-mediated inhibition (Figure 8B). Thus, fatty acid catabolism provides β-hydroxybutyrate, which acts as a secondary signal to initiate the de-repression of the Fgf21 promoter by HDAC3, allowing it to become PPARα responsive. It was previously indicated that HDAC-mediated histone deacetylation may inhibit transcription at the initiation and/or elongation step (Wang et al., 2009). If the genes are loaded by Pol2 at the TSS, similar to what we observed at the Fgf21 TSS upon PPARα agonistic activation, HDAC-mediated inhibition of transcription most likely happens at the elongation step although abortive initiation of the TSS bound Pol2 cannot be excluded. Our results suggest that PPARα activation induces the recruitment and assembly of a transcription initiation complex at the Fgf21 TSS. However, the elongation of Fgf21 mRNA transcript only ensues after alleviation of HDAC3 inhibition by β-hydroxybutyrate. Therefore, it is consistent with our findings that PPARα agonist has no effect on Fgf21 mRNA or transcriptional activation in the absence of β-hydroxybutyrate.

Both human and mouse neonates exhibit mild ketogenic conditions during early postpartum period (0–1 day, 0.2–0.5 mmol/L), which further exacerbates after 5–10 days (0.5–1.1 mmol/L) (Hamosh, 2004). We believe that it could be due to the use of lipids as preferred fuel for growth while the carbohydrate parts of milk (e.g., lactose and oligosaccharide−two main carbohydrates in milk) mainly contribute to brain growth (i.e., myelin synthesis) and gut microbiota nourishment (Edmond, 1992; Chichlowski et al., 2011). Further, the observed ketogenic condition may also be explained by the low insulin/glucagon ratio in early postpartum life (Girard et al., 1977; Ferré et al., 1979; Girard et al., 1992). We found that ketone bodies act as a hit that is important to prime PPARα-dependent expressions of Fgf21 and Angptl4 by modulating HDAC3 activity on their promoter. Both FGF21 and ANGPTL4 function as secreted systemic effectors of PPARα (Badman et al., 2007; Dijk and Kersten, 2014). However, unlike Fgf21, the expression of Angptl4 has already begun in the fetal liver. This finding is congruent with the report that ANGPTL4 functions as a glucocorticoid-dependent gatekeeper of FA flux by inhibiting the activity of adipose tissue lipoprotein lipase during fasting (Koliwad et al., 2012; Dijk and Kersten, 2014). In fact, significant overlap exists between the bioenergetic challenges experienced during fasting and at birth. Liver-derived FGF21 acts as an endocrine regulator of ketogenesis, which links the phenotypes observed during fasting and in newborns (Badman et al., 2007; Hondares et al., 2010). This concept is evident in Ppara^-/- mice, which have reduced plasma FGF21 levels. During fasting, the switch to a lipid-dominated nutrient supply provokes hypoketonemia, hypoglycemia, and hepatic steatosis in adult Ppara^-/- mice (Kersten et al., 1999; Montagner et al., 2016). In concordance with a recent report (Cotter et al., 2014), the shift to a high-fat, low-carbohydrate ketogenic diet in Ppara^-/- neonates results in steatosis similar to that observed in fasted adult Ppara^-/- mice. Notably, FGF21 has previously been shown to stimulate hepatic FAO and to prevent hepatic steatosis following ingestion of lipid-laden milk (Xu et al., 2009). Hence, we believe that the physiological relevance of FGF21 induction in neonates after milk suckling relates to its role in metabolic regulation by stimulating lipid catabolism rather than a response to starvation or a low calorie condition which no longer exists upon milk ingestion. It is also important to note that the early human breast milk is not initially ketogenic due to the relatively high lactose content, which gradually decreases while the fat content increases as the milk matures over time (Jenness, 1979). In contrast, mouse milk is likely a ketogenic diet as evidenced by a previous report that early mouse milk comprises ~17% of fat and ~1.7% of lactose at P3 (Görs et al., 2004). Therefore, direct translation of our findings to human situations needs to be cautioned for such differences in milk composition.

In summary, we provide evidence that prenatal expression of PPARα is under the direct control of GR. The GR-dependent PPARα activity is pivotal for the induction of hepatic FA catabolic genes, pointing to a novel anticipatory role of PPARα in the fetal liver in preparation for the efficient use of milk fat as an energy source. In addition, hepatic FA catabolism provides essential co-factors for the synthesis of ketone bodies such as β-hydroxybutyrate. Interestingly, ketone bodies act as a secondary signal that further activates PPARα-dependent regulation of the hepatokine FGF21. Therefore GR-PPARα axis may represent a critical signaling pathway in late gestation for the ability of mammalian newborns to use nutrients and maintain whole-body homeostasis. We conclude that in the absence of PPARα, a vicious cycle pertaining to the (i) lower mitochondria numbers, (ii) mitochondrial dysfunctions, (iii) impaired mitochondrial FA β-oxidation, (iii) hypoketonemia either due to a lack of direct PPARα stimulation of Hmgcs2 or a lack of essential co-factors provided by functional FAO, (iv) lack of epigenetic activation of FGF21 by ketone bodies (e.g., β-hydroxybutyrate), and (v) a surge in nutritional lipids upon milk suckling, exists to concomitantly contribute to the development of hepatic steatosis in neonates (Figure 8C).

1. 1. Gianpaolo R
   2. Nourhène K
   3. Walter W

   (2016) Prenatal PPARa-dependent gene expression in fetal mouse liver just before birth (E19.5)

   Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE39669).

   http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39669
2. 1. Gianpaolo R
   2. Nourhène K
   3. Walter W

   (2016) Postnatal PPARa-dependent gene expression in two-days old mouse liver

   Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE39670).

   http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39670

1. 1. Aguer C
   2. Gambarotta D
   3. Mailloux RJ
   4. Moffat C
   5. Dent R
   6. McPherson R
   7. Harper ME

   (2011) Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells

   PLoS One 6:e28536.

   https://doi.org/10.1371/journal.pone.0028536

   • Google Scholar
2. 1. Anderson SP
   2. Yoon L
   3. Richard EB
   4. Dunn CS
   5. Cattley RC
   6. Corton JC

   (2002) Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice

   Hepatology 36:544–554.

   https://doi.org/10.1053/jhep.2002.35276

   • Google Scholar
3. 1. Archer A
   2. Venteclef N
   3. Mode A
   4. Pedrelli M
   5. Gabbi C
   6. Clément K
   7. Parini P
   8. Gustafsson JÅ
   9. Korach-André M

   (2012) Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice

   Molecular Endocrinology 26:1980–1990.

   https://doi.org/10.1210/me.2012-1151

   • Google Scholar
4. 1. Badman MK
   2. Pissios P
   3. Kennedy AR
   4. Koukos G
   5. Flier JS
   6. Maratos-Flier E

   (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

   Cell Metabolism 5:426–437.

   https://doi.org/10.1016/j.cmet.2007.05.002

   • Google Scholar
5. 1. Barlow SM
   2. Morrison PJ
   3. Sullivan FM

   (1974) Plasma corticosterone levels during pregnancy in the mouse: the relative contributions of the adrenal glands and foeto-placental units

   Journal of Endocrinology 60:473–483.

   https://doi.org/10.1677/joe.0.0600473

   • Google Scholar
6. 1. Bougarne N
   2. Paumelle R
   3. Caron S
   4. Hennuyer N
   5. Mansouri R
   6. Gervois P
   7. Staels B
   8. Haegeman G
   9. De Bosscher K

   (2009) PPARα blocks glucocorticoid receptor α-mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF-κB

   PNAS 106:7397–7402.

   https://doi.org/10.1073/pnas.0806742106

   • Google Scholar
7. 1. Brawand D
   2. Wahli W
   3. Kaessmann H

   (2008) Loss of egg yolk genes in mammals and the origin of lactation and placentation

   PLoS Biology 6:e63.

   https://doi.org/10.1371/journal.pbio.0060063

   • Google Scholar
8. 1. Chakravarthy MV
   2. Lodhi IJ
   3. Yin L
   4. Malapaka RR
   5. Xu HE
   6. Turk J
   7. Semenkovich CF

   (2009) Identification of a physiologically relevant endogenous ligand for PPARalpha in liver

   Cell 138:476–488.

   https://doi.org/10.1016/j.cell.2009.05.036

   • Google Scholar
9. 1. Chakravarthy MV
   2. Pan Z
   3. Zhu Y
   4. Tordjman K
   5. Schneider JG
   6. Coleman T
   7. Turk J
   8. Semenkovich CF

   (2005) "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis

   Cell Metabolism 1:309–322.

   https://doi.org/10.1016/j.cmet.2005.04.002

   • Google Scholar
10. 1. Cherkaoui-Malki M
    2. Surapureddi S
    3. El-Hajj HI
    4. Vamecq J
    5. Andreoletti P

    (2012) Hepatic steatosis and peroxisomal fatty acid beta-oxidation

    Current Drug Metabolism 13:1412–1421.

    https://doi.org/10.2174/138920012803762765

    • Google Scholar
11. 1. Chichlowski M
    2. German JB
    3. Lebrilla CB
    4. Mills DA

    (2011) The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas

    Annual Review of Food Science and Technology 2:331–351.

    https://doi.org/10.1146/annurev-food-022510-133743

    • Google Scholar
12. 1. Cole TJ
    2. Blendy JA
    3. Monaghan AP
    4. Krieglstein K
    5. Schmid W
    6. Aguzzi A
    7. Fantuzzi G
    8. Hummler E
    9. Unsicker K
    10. Schütz G

    (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

    Genes & Development 9:1608–1621.

    https://doi.org/10.1101/gad.9.13.1608

    • Google Scholar
13. 1. Cotter DG
    2. Ercal B
    3. d'Avignon DA
    4. Dietzen DJ
    5. Crawford PA

    (2013) Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth

    Journal of Biological Chemistry 288:19739–19749.

    https://doi.org/10.1074/jbc.M113.454868

    • Google Scholar
14. 1. Cotter DG
    2. Ercal B
    3. d'Avignon DA
    4. Dietzen DJ
    5. Crawford PA

    (2014) Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice

    American Journal of Physiology. Endocrinology and Metabolism 307:E176–185.

    https://doi.org/10.1152/ajpendo.00087.2014

    • Google Scholar
15. 1. Cottrell EC
    2. Seckl JR

    (2009) Prenatal stress, glucocorticoids and the programming of adult disease

    Frontiers in Behavioral Neuroscience 3:19.

    https://doi.org/10.3389/neuro.08.019.2009

    • Google Scholar
16. 1. Desvergne B
    2. Michalik L
    3. Wahli W

    (2006) Transcriptional regulation of metabolism

    Physiological Reviews 86:465–514.

    https://doi.org/10.1152/physrev.00025.2005

    • Google Scholar
17. 1. Dijk W
    2. Kersten S

    (2014) Regulation of lipoprotein lipase by Angptl4

    Trends in Endocrinology & Metabolism 25:146–155.

    https://doi.org/10.1016/j.tem.2013.12.005

    • Google Scholar
18. 1. Edmond J

    (1992) Energy metabolism in developing brain cells

    Canadian Journal of Physiology and Pharmacology 70 Suppl:S118–S129.

    https://doi.org/10.1139/y92-253

    • Google Scholar
19. 1. Estall JL
    2. Ruas JL
    3. Choi CS
    4. Laznik D
    5. Badman M
    6. Maratos-Flier E
    7. Shulman GI
    8. Spiegelman BM

    (2009) PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis

    PNAS 106:22510–22515.

    https://doi.org/10.1073/pnas.0912533106

    • Google Scholar
20. 1. Feng D
    2. Liu T
    3. Sun Z
    4. Bugge A
    5. Mullican SE
    6. Alenghat T
    7. Liu XS
    8. Lazar MA

    (2011) A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism

    Science 331:1315–1319.

    https://doi.org/10.1126/science.1198125

    • Google Scholar
21. 1. Ferré P
    2. Pégorier JP
    3. Williamson DH
    4. Girard J

    (1979) Interactions in vivo between oxidation of non-esterified fatty acids and gluconeogenesis in the newborn rat

    Biochemical Journal 182:593–598.

    https://doi.org/10.1042/bj1820593

    • Google Scholar
22. Book

    1. Girard J
    2. Ferré P
    3. Kervran A
    4. Pegorier JP
    5. Assan R

    (1977) Role of the insulin/glucagon ratio in the changes of hepatic metabolism during development of the rat

    In: Foa P. P, Bajaj J. S, Foa N. L, Bivens L, editors. Glucagon: Its Role in Physiology and Clinical Medicine. New York: Springer. pp. 563–581.

    https://doi.org/10.1007/978-1-4612-6366-1_36

    • Google Scholar
23. 1. Girard J
    2. Ferré P
    3. Pégorier JP
    4. Duée PH

    (1992)

    Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition

    Physiological Reviews 72:507–562.

    • Google Scholar
24. 1. Girard J

    (1986) Gluconeogenesis in Late Fetal and Early Neonatal Life

    Neonatology 50:237–258.

    https://doi.org/10.1159/000242605

    • Google Scholar
25. 1. Görs S
    2. Kucia M
    3. Langhammer M
    4. Junghans P
    5. Metges CC

    (2009) Technical note: Milk composition in mice--methodological aspects and effects of mouse strain and lactation day

    Journal of Dairy Science 92:632–637.

    https://doi.org/10.3168/jds.2008-1563

    • Google Scholar
26. Book

    1. Hamosh M

    (2004) Human Milk Composition and Function in the Infant

    In: Polin R, Fox W, Abman S, editors. Fetal and Neonatal Physiology . Elsevier Inc. pp. 275–284.

    https://doi.org/10.1016/b978-0-7216-9654-6.50032-1

    • Google Scholar
27. 1. Hashimoto T
    2. Fujita T
    3. Usuda N
    4. Cook W
    5. Qi C
    6. Peters JM
    7. Gonzalez FJ
    8. Yeldandi AV
    9. Rao MS
    10. Reddy JK

    (1999) Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype

    Journal of Biological Chemistry 274:19228–19236.

    https://doi.org/10.1074/jbc.274.27.19228

    • Google Scholar
28. 1. Hondares E
    2. Rosell M
    3. Gonzalez FJ
    4. Giralt M
    5. Iglesias R
    6. Villarroya F

    (2010) Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat

    Cell Metabolism 11:206–212.

    https://doi.org/10.1016/j.cmet.2010.02.001

    • Google Scholar
29. 1. Huyghe S
    2. Casteels M
    3. Janssen A
    4. Meulders L
    5. Mannaerts GP
    6. Declercq PE
    7. Van Veldhoven PP
    8. Baes M

    (2001) Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse

    Biochemical Journal 353:673–680.

    https://doi.org/10.1042/bj3530673

    • Google Scholar
30. 1. Ibarra-Lara L
    2. Del Valle-Mondragón L
    3. Soria-Castro E
    4. Torres-Narváez JC
    5. Pérez-Severiano F
    6. Sánchez-Aguilar M
    7. Ramírez-Ortega M
    8. Cervantes-Pérez LG
    9. Pastelín-Hernández GS
    10. Oidor-Chan VH
    11. Zarco-Olvera G
    12. Sánchez-Mendoza A
    13. Ramírez-Ortega M
    14. Sánchez-Mendoza A

    (2016) Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle

    Pharmacological Reports 68:692–702.

    https://doi.org/10.1016/j.pharep.2016.03.002

    • Google Scholar
31. 1. Ibdah JA
    2. Paul H
    3. Zhao Y
    4. Binford S
    5. Salleng K
    6. Cline M
    7. Matern D
    8. Bennett MJ
    9. Rinaldo P
    10. Strauss AW

    (2001) Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death

    Journal of Clinical Investigation 107:1403–1409.

    https://doi.org/10.1172/JCI12590

    • Google Scholar
32. 1. Jenness R

    (1979)

    The composition of human milk

    Seminars in Perinatology 3:225–239.

    • Google Scholar
33. 1. Josekutty J
    2. Iqbal J
    3. Iwawaki T
    4. Kohno K
    5. Hussain MM

    (2013) Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST

    Journal of Biological Chemistry 288:14372–14383.

    https://doi.org/10.1074/jbc.M113.459602

    • Google Scholar
34. 1. Kersten S
    2. Seydoux J
    3. Peters JM
    4. Gonzalez FJ
    5. Desvergne B
    6. Wahli W

    (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

    Journal of Clinical Investigation 103:1489–1498.

    https://doi.org/10.1172/JCI6223

    • Google Scholar
35. 1. Koliwad SK
    2. Gray NE
    3. Wang JC

    (2012) Angiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting

    Adipocyte 1:182–187.

    https://doi.org/10.4161/adip.20787

    • Google Scholar
36. 1. Krahling JB
    2. Gee R
    3. Gauger JA
    4. Tolbert NE

    (1979) Postnatal development of peroxisomal and mitochondrial enzymes in rat liver

    Journal of Cellular Physiology 101:375–390.

    https://doi.org/10.1002/jcp.1041010305

    • Google Scholar
37. 1. Lebiedzinska M
    2. Karkucinska-Wieckowska A
    3. Giorgi C
    4. Karczmarewicz E
    5. Pronicka E
    6. Pinton P
    7. Duszynski J
    8. Pronicki M
    9. Wieckowski MR

    (2010) Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders

    Biochimica Et Biophysica Acta 1797:952–960.

    https://doi.org/10.1016/j.bbabio.2010.03.005

    • Google Scholar
38. 1. Lemberger T
    2. Staels B
    3. Saladin R
    4. Desvergne B
    5. Auwerx J
    6. Wahli W

    (1994)

    Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids

    Journal of Biological Chemistry 269:24527–24530.

    • Google Scholar
39. 1. Leuenberger N
    2. Pradervand S
    3. Wahli W

    (2009) Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice

    Journal of Clinical Investigation 119:3138–3148.

    https://doi.org/10.1172/JCI39019

    • Google Scholar
40. 1. Montagner A
    2. Polizzi A
    3. Fouché E
    4. Ducheix S
    5. Lippi Y
    6. Lasserre F
    7. Barquissau V
    8. Régnier M
    9. Lukowicz C
    10. Benhamed F
    11. Iroz A
    12. Bertrand-Michel J
    13. Al Saati T
    14. Cano P
    15. Mselli-Lakhal L
    16. Mithieux G
    17. Rajas F
    18. Lagarrigue S
    19. Pineau T
    20. Loiseau N
    21. Postic C
    22. Langin D
    23. Wahli W
    24. Guillou H

    (2016) Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

    Gut 65:1202–1214.

    https://doi.org/10.1136/gutjnl-2015-310798

    • Google Scholar
41. 1. Montagner A
    2. Rando G
    3. Degueurce G
    4. Leuenberger N
    5. Michalik L
    6. Wahli W

    (2011) New insights into the role of PPARs

    Prostaglandins, Leukotrienes and Essential Fatty Acids 85:235–243.

    https://doi.org/10.1016/j.plefa.2011.04.016

    • Google Scholar
42. 1. Nasrin N
    2. Wu X
    3. Fortier E
    4. Feng Y
    5. Bare' OC
    6. Chen S
    7. Ren X
    8. Wu Z
    9. Streeper RS
    10. Bordone L

    (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells

    Journal of Biological Chemistry 285:31995–32002.

    https://doi.org/10.1074/jbc.M110.124164

    • Google Scholar
43. 1. Ockner RK
    2. Kaikaus RM
    3. Bass NM

    (1993) Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis

    Hepatology 18:669–676.

    https://doi.org/10.1002/hep.1840180327

    • Google Scholar
44. 1. Perry RJ
    2. Camporez JP
    3. Kursawe R
    4. Titchenell PM
    5. Zhang D
    6. Perry CJ
    7. Jurczak MJ
    8. Abudukadier A
    9. Han MS
    10. Zhang XM
    11. Ruan HB
    12. Yang X
    13. Caprio S
    14. Kaech SM
    15. Sul HS
    16. Birnbaum MJ
    17. Davis RJ
    18. Cline GW
    19. Petersen KF
    20. Shulman GI

    (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes

    Cell 160:745–758.

    https://doi.org/10.1016/j.cell.2015.01.012

    • Google Scholar
45. 1. Rakhshandehroo M
    2. Knoch B
    3. Müller M
    4. Kersten S

    (2010) Peroxisome proliferator-activated receptor alpha target genes

    PPAR Research 2010:.

    https://doi.org/10.1155/2010/612089

    • Google Scholar
46. 1. Reddy JK
    2. Mannaerts GP

    (1994) Peroxisomal lipid metabolism

    Annual Review of Nutrition 14:343–370.

    https://doi.org/10.1146/annurev.nu.14.070194.002015

    • Google Scholar
47. 1. Rodríguez JC
    2. Gil-Gómez G
    3. Hegardt FG
    4. Haro D

    (1994)

    Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids

    Journal of Biological Chemistry 269:18767–18772.

    • Google Scholar
48. 1. Salgado MC
    2. Metón I
    3. Anemaet IG
    4. Baanante IV

    (2014) Activating transcription factor 4 mediates up-regulation of alanine aminotransferase 2 gene expression under metabolic stress

    Biochimica Et Biophysica Acta 1839:288–296.

    https://doi.org/10.1016/j.bbagrm.2014.01.005

    • Google Scholar
49. 1. Serra D
    2. Bellido D
    3. Asins G
    4. Arias G
    5. Vilaró S
    6. Hegardt FG

    (1996) The expression of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme-A synthase in neonatal rat intestine and liver is under transcriptional control

    European Journal of Biochemistry 237:16–24.

    https://doi.org/10.1111/j.1432-1033.1996.0016n.x

    • Google Scholar
50. 1. Serra D
    2. Casals N
    3. Asins G
    4. Royo T
    5. Ciudad CJ
    6. Hegardt FG

    (1993) Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes

    Archives of Biochemistry and Biophysics 307:40–45.

    https://doi.org/10.1006/abbi.1993.1557

    • Google Scholar
51. 1. Shimazu T
    2. Hirschey MD
    3. Newman J
    4. He W
    5. Shirakawa K
    6. Le Moan N
    7. Grueter CA
    8. Lim H
    9. Saunders LR
    10. Stevens RD
    11. Newgard CB
    12. Farese RV
    13. de Cabo R
    14. Ulrich S
    15. Akassoglou K
    16. Verdin E

    (2013) Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor

    Science 339:211–214.

    https://doi.org/10.1126/science.1227166

    • Google Scholar
52. 1. Smith S
    2. Watts R
    3. Dils R

    (1968)

    Quantitative gas-liquid chromatographic analysis of rodent milk triglycerides

    Journal of Lipid Research 9:52–57.

    • Google Scholar
53. 1. Speirs HJ
    2. Seckl JR
    3. Brown RW

    (2004) Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development

    Journal of Endocrinology 181:105–116.

    https://doi.org/10.1677/joe.0.1810105

    • Google Scholar
54. 1. Strober W

    (2001) Trypan blue exclusion test of cell viability

    Current Protocols in Immunology Appendix 3:Appendix 3B.

    https://doi.org/10.1002/0471142735.ima03bs21

    • Google Scholar
55. 1. Su Q
    2. Baker C
    3. Christian P
    4. Naples M
    5. Tong X
    6. Zhang K
    7. Santha M
    8. Adeli K

    (2014) Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis

    Endocrinology and Metabolism 306:E1264–E1273.

    https://doi.org/10.1152/ajpendo.00438.2013

    • Google Scholar
56. 1. Suski JM
    2. Lebiedzinska M
    3. Bonora M
    4. Pinton P
    5. Duszynski J
    6. Wieckowski MR

    (2012) Relation between mitochondrial membrane potential and ROS formation

    Methods in Molecular Biology 810:183–205.

    https://doi.org/10.1007/978-1-61779-382-0_12

    • Google Scholar
57. 1. Tanimizu N
    2. Nishikawa M
    3. Saito H
    4. Tsujimura T
    5. Miyajima A

    (2003) Isolation of hepatoblasts based on the expression of Dlk/Pref-1

    Journal of Cell Science 116:1775–1786.

    https://doi.org/10.1242/jcs.00388

    • Google Scholar
58. 1. Tirosh O
    2. Ilan E
    3. Anavi S
    4. Ramadori G
    5. Madar Z

    (2009) Nutritional lipid-induced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes

    Nutrition 25:200–208.

    https://doi.org/10.1016/j.nut.2008.07.023

    • Google Scholar
59. 1. Tugwood JD
    2. Issemann I
    3. Anderson RG
    4. Bundell KR
    5. McPheat WL
    6. Green S

    (1992)

    The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

    The EMBO Journal 11:433–439.

    • Google Scholar
60. 1. Vilà-Brau A
    2. De Sousa-Coelho AL
    3. Mayordomo C
    4. Haro D
    5. Marrero PF

    (2011) Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line

    Journal of Biological Chemistry 286:20423–20430.

    https://doi.org/10.1074/jbc.M111.235044

    • Google Scholar
61. 1. Wang Z
    2. Zang C
    3. Cui K
    4. Schones DE
    5. Barski A
    6. Peng W
    7. Zhao K

    (2009) Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes

    Cell 138:1019–1031.

    https://doi.org/10.1016/j.cell.2009.06.049

    • Google Scholar
62. 1. Xu J
    2. Lloyd DJ
    3. Hale C
    4. Stanislaus S
    5. Chen M
    6. Sivits G
    7. Vonderfecht S
    8. Hecht R
    9. Li YS
    10. Lindberg RA
    11. Chen JL
    12. Jung DY
    13. Zhang Z
    14. Ko HJ
    15. Kim JK
    16. Véniant MM
    17. Young Jung D

    (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

    Diabetes 58:250–259.

    https://doi.org/10.2337/db08-0392

    • Google Scholar
63. 1. Xu J
    2. Xiao G
    3. Trujillo C
    4. Chang V
    5. Blanco L
    6. Joseph SB
    7. Bassilian S
    8. Saad MF
    9. Tontonoz P
    10. Lee WN
    11. Kurland IJ

    (2002) Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production

    Journal of Biological Chemistry 277:50237–50244.

    https://doi.org/10.1074/jbc.M201208200

    • Google Scholar
64. 1. Yubero P
    2. Hondares E
    3. Carmona MC
    4. Rossell M
    5. Gonzalez FJ
    6. Iglesias R
    7. Giralt M
    8. Villarroya F

    (2004) The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism

    Endocrinology 145:4268–4277.

    https://doi.org/10.1210/en.2004-0099

    • Google Scholar
65. 1. Zadravec D
    2. Brolinson A
    3. Fisher RM
    4. Carneheim C
    5. Csikasz RI
    6. Bertrand-Michel J
    7. Borén J
    8. Guillou H
    9. Rudling M
    10. Jacobsson A

    (2010) Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity

     FASEB Journal 24:4366–4377.

    https://doi.org/10.1096/fj.09-152298

    • Google Scholar

Author details

1. Gianpaolo Rando

   Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland

   Contribution

   GR, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article

   Contributed equally with

   Chek Kun Tan

   Competing interests

   The authors declare that no competing interests exist.

2. Chek Kun Tan

   Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

   Contribution

   CKT, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article

   Contributed equally with

   Gianpaolo Rando

   Competing interests

   The authors declare that no competing interests exist.

3. Nourhène Khaled

   Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland

   Contribution

   NK, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

4. Alexandra Montagner

   UMR 1331 ToxAlim Research Centre in Food Toxicology, INRA, Université de Toulouse, Toulouse, France

   Contribution

   AM, Contributed to the experiments, Data acquisition, Revised the manuscript, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

5. Nicolas Leuenberger

   Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland

   Contribution

   NL, Contributed to the experiments, Data acquisition, Revised the manuscript, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

6. Justine Bertrand-Michel

   IFR 150 Plateforme Metatoul, Institut Fédératif de Recherche Bio-Médicale de Toulouse INSERM U563, Toulouse, France

   Contribution

   JB-M, Contributed to the experiments, Data acquisition, Revised the manuscript, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

7. Eeswari Paramalingam

   Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

   Contribution

   EP, Contributed to the experiments, Data acquisition, Revised the manuscript, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

8. Hervé Guillou

   UMR 1331 ToxAlim Research Centre in Food Toxicology, INRA, Université de Toulouse, Toulouse, France

   Contribution

   HG, Contributed to the experiments, Data acquisition, Revised the manuscript, Acquisition of data, Analysis and interpretation of data

   Competing interests

   The authors declare that no competing interests exist.

9. Walter Wahli

   1. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
   2. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
   3. UMR 1331 ToxAlim Research Centre in Food Toxicology, INRA, Université de Toulouse, Toulouse, France

   Contribution

   WW, Designed the study and was involved in all aspects of the experiments, Wrote the manuscript, Supervised this study, Analysis and interpretation of data

   For correspondence

   walter.wahli@ntu.edu.sg

   Competing interests

   The authors declare that no competing interests exist.

   "This ORCID iD identifies the author of this article:" 0000-0002-5966-9089

• 2,921

  views

• 575

  downloads

• 43

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.